A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

NCT06082986 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Ustekinumab

Sponsor

Xian-Janssen Pharmaceutical Ltd.